The acquisition would add to Vertex’s pipeline and potentially grow its annual revenue by $5 billion with the addition of Crinetics-developed drugs Palsonify and Atumelnant, the company said.
Source link
Vertex Pharmaceuticals to Acquire Crinetics Pharmaceuticals for $10 Billion
Date:
More like thisRelated
Toyota to Move Tacoma Production to Texas in $3.6 Billion U.S. Expansion Plan
The automaker will boost vehicle production at its San...
USMNT player ratings: Pulisic & Co. struggle in World Cup exit
Ryan S. ClarkJul 6, 2026, 10:14 PM ETCloseRyan S....
The U.S. had a golden opportunity for a soccer breakthrough. Now it must wait four more years.
SEATTLE — The U.S. men’s soccer team entered the...
Tanker set ablaze after being struck in Strait of Hormuz
A tanker traveling off the coast of Oman in...